Scinovex
article Open AccessTop 1% cited

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American Journal of Transplantation · 2004 · Vol. 4(4) · pp. 611–620
Carlos V. PayáAtul HumarEd DominguezKenneth WashburnEmily A. BlumbergBarbara D. AlexanderRichard B. FreemanNigel HeatonMark D. Pescovitz
Cytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsToxoplasma gondii Research StudiesValganciclovirGanciclovirMedicineInternal medicineCytomegalovirusGastroenterologyViremiaSurgeryHuman cytomegalovirusImmunology

MeSH terms

ValganciclovirAdministration, OralAdultAntiviral AgentsCytomegalovirus InfectionsDouble-Blind MethodFemaleGraft RejectionGraft SurvivalHumansMaleMiddle AgedPostoperative ComplicationsProspective StudiesTime Factors

Funding

  • University of Minnesota
  • Johns Hopkins University
  • Loma Linda University
Citations
880
FWCI
41.32
field-weighted impact
References
32
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.